Goserelin
Spécifications
65807-02-5Numéro CAS
686-281-6Numéro CE
(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amiNom IUPAC
C59H84N18O14Formule chimique
1269.4 g/molMasse molaire
goserelin; 65807-02-5; Decapeptide I; Goserelina; Gosereline; Goserelinum; ICI-118630; ICI 118630; ICI 118,630; 0F65R8P09N; DTXSID7048297; ICI118630; Acetate, Goserelin; RefChem:57538; DTXCID2028272; L02AE03; 6-(O-(1,1-Dimethylethyl)-D-serine)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig) 2-(aminocarbonyl)hydrazide; (2S)-1-((2S)-2-((2S)-2-((2R)-3-(tert-butoxy)-2-((2S)-2-((2S)-3-hydroxy-2-((2S)-2-((2S)-3-(1H-imidazol-5-yl)-2-(((2S)-5-oxopyrrolidin-2-yl)formamido)propanamido)-3-(1H-indol-3-yl)propanamido)propanamido)-3-(4-hydroxyphenyl)propanamido)propanamido)-4-methylpentanamido)-5-((diaminomethylidene)amino)pentanoyl)-N-(carbamoylamino)pyrrolidine-2-carboxamide; (2S)-N-((2S)-1-(((2S)-1-(((2S)-1-(((2S)-1-(((2R)-1-(((2S)-1-(((2S)-1-((2S)-2-((carbamoylamino)carbamoyl)pyrrolidin-1-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-3-((2-methylpropan-2-yl)oxy)-1-oxopropan-2-yl)amino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)amino)-3-hydroxy-1-oxopropan-2-yl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-3-(3H-imidazol-4-yl)-1-oxopropan-2-yl)-5-oxopyrrolidine-2-carboxamide; Zoladex; 1-(5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-O-tert-butyl-D-seryl-L-leucyl-L-arginyl-L-prolyl)semicarbazide; 1233494-97-7; Gosereline [French]; Goserelinum [Latin]; Goserelina [Spanish]; Goserelin [USAN:INN:BAN]; UNII-0F65R8P09N; goserelin-acetate; Goserelin CRS; HSDB 7606; C59H84N18O14; MFCD00867894; HS-2015; ZD-9393; GOSERELIN [INN]; GOSERELIN [MI]; Goserelin (USAN/INN); GOSERELIN [HSDB]; GOSERELIN [USAN]; D-Ser(t-Bu)(sup 6)aza-gly(sup 10)-GNRH; GOSERELIN [MART.]; GOSERELIN [WHO-DD]; SCHEMBL8643; (2S)-1-[(2S)-2-[(2S)-2-[(2R)-3-(TERT-BUTOXY)-2-[(2S)-2-[(2S)-3-HYDROXY-2-[(2S)-2-[(2S)-3-(1H-IMIDAZOL-4-YL)-2-{[(2S)-5-OXOPYRROLIDIN-2-YL]FORMAMIDO}PROPANAMIDO]-3-(1H-INDOL-3-YL)PROPANAMIDO]PROPANAMIDO]-3-(4-HYDROXYPHENYL)PROPANAMIDO]PROPANAMIDO]-4-METHYLPENTANAMIDO]-5-CARBAMIMIDAMIDOPENTANOYL]-N-(CARBAMOYLAMINO)PYRROLIDINE-2-CARBOXAMIDE; CHEBI:5523; GTPL3879; orb1179810; CHEMBL1201247; GOSERELIN [EP MONOGRAPH]; SCHEMBL19712239; SCHEMBL20459194; SCHEMBL29381733; SCHEMBL29405686; SCHEMBL29551046; SCHEMBL29833872; HMS2089D16; BDBM50247974; EBC-27545; EX-A15488; Goserelin for NMR identification CRS; AKOS015994653; AKOS030213245; DB00014; NCGC00390804-01; (S)-N-((6S,9S,12R,15S,18S,21S,24S)-21-((1H-indol-3-yl)methyl)-1-amino-12-(tert-butoxymethyl)-6-((S)-2-(2-carbamoylhydrazine-1-carbonyl)pyrrolidine-1-carbonyl)-15-(4-hydroxybenzyl)-18-(hydroxymethyl)-25-(1H-imidazol-4-yl)-1-imino-9-isobutyl-8,11,14,17,20,23-hexaoxo-2,7,10,13,16,19,22-heptaazapentacosan-24-yl)-5-oxopyrrolidine-2-carboxamide; FS110042; HY-13673; NS00120430; (D-Ser(tBu)6,Azagly10)-LHRH (free base); D04405; AB01275466-01; EN300-7480905; Q1992653; BRD-K99504665-001-01-2; (S)-N-((6S,9S,12R,15S,18S,21S,24S)-21-((1H-indol-3-yl)methyl)-1,1-diamino-12-(tert-butoxymethyl)-6-((S)-2-(2-carbamoylhydrazine-1-carbonyl)pyrrolidine-1-carbonyl)-15-(4-hydroxybenzyl)-18-(hydroxymethyl)-25-(1H-imidazol-5-yl)-9-isobutyl-8,11,14,17,20,23-hexaoxo-2,7,10,13,16,19,22-heptaazapentacos-1-en-24-yl)-5-oxopyrrolidine-2-carboxamideSynonymes
